IFF divests select botanical and ingredients portfolio to SuanNutra
The companies did not disclose the financial terms of the transaction in the public statements cited by market reports.
USA – IFF has agreed to sell its botanical extracts, vitamins and minerals, and food enhancement businesses to SuanNutra, a Carbyne Equity Partners portfolio company and supplier of branded functional ingredients.
The deal also covers IFF’s natural colours and antioxidants range, along with certain localized flavour activities in Peru.
Together, the businesses being sold generated about USD 170 million in revenue in 2025 and employed roughly 600 people across five manufacturing sites in Europe, the United States and Latin America.
Erik Fyrwald, CEO of IFF, stated, “These businesses are highly respected, and we are confident they will continue to thrive under the ownership of SuanNutra and Carbyne.”
“This transaction is another step in optimizing our portfolio and reinforces our focus on our core innovation-led businesses, Taste, Scent and Health & Biosciences, where we see the greatest opportunities to drive long-term profitable growth and create value for our shareholders.”
The companies did not disclose the financial terms of the sale, and they expect the transaction to close by the end of 2026, subject to customary closing conditions, including regulatory approvals and required consultation processes.
Alantra is advising IFF on the deal, while DLA Piper is serving as legal counsel.
Meanwhile, IFF recently entered into a definitive agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, for a transaction valued at USD 4.3 billion, representing an enterprise value-to-EBITDA multiple of roughly 10x.
The transaction will deliver approximately USD 3.8 billion in net cash proceeds at closing, which IFF plans to deploy for debt reduction, authorized share repurchases, and reinvestment in its core businesses.
IFF will retain a 10% minority equity interest in the divested Food Ingredients business, valued at approximately USD 200 million, and will maintain a board seat to continue collaboration while allowing IFF and its shareholders to participate in future value creation under CVC’s ownership.
The deal is expected to close by the end of the second quarter of 2027, subject to regulatory approvals and customary closing conditions, with JPMorgan and Bank of America serving as financial advisors to IFF.
Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.
